Delivery Order SPE2DB24D2205-SPE2DB25FEFZK
- Not listed
- The Defense Logistics Agency (DLA) awarded a $4.76K delivery order to AmerisourceBergen Drug Corp for OmniPod Dash Pods (Gen 4) in five-packs, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a continuation of AmerisourceBergen's role as a critical supplier of pharmaceutical products and medical devices...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for OmniPod Dash Pods (Gen 4) 5-packs valued at $1,030.73. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be performed at the contractor's location in...
- The Defense Logistics Agency awarded a $3,096.47 delivery order to AmerisourceBergen Drug Corp for OmniPod Dash Pods (Generation 4) 5-packs, with an ultimate completion date of August 5, 2025. This non-competitive delivery order represents a firm fixed price contract and constitutes a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The OmniPod Dash system is a tubeless insulin infusion pump used for diabetes management, and this...
- The Defense Logistics Agency awarded a $7,815.50 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for OmniPod Dash Pods (Gen 4) 5-packs. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. The medical supplies will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,986.13, is for the delivery of Omnipod Dash Pods (Gen 4) 5PK 5S medical devices. The order has a completion date of March 27, 2025 and is not associated with any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $3,499.22 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OMNIPOD DASH PODS (GEN 4) 5PK 5S medical devices, with a period of performance through January 10, 2025. This award is a delivery order under a larger, $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of OMNIPOD DASH PODS (GEN 4) 5PK 5S medical devices. The contract has a firm fixed price of $1,134.60 and a performance period through June 10, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OMNIPOD DASH PODS (GEN 4) 5PK 5S, a medical device product, with a firm fixed price ceiling value of $7,444.59 and a performance period through June 25, 2025. This order is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Omnipod Dash Pods (Gen 4) 5-packs. The $8,698.72 fixed-price contract has an ultimate completion date of April 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD DASH PODS (GEN 4) 5PK 5S, a medical device used in the management of diabetes. The contract has a ceiling value of $2,351.58 and an ultimate completion date of June 9, 2025. This is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFZKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OmniPod Dash Pods (Generation 4) in 5-packs on August 7, 2025, with a ceiling value of $1,134.60. This firm fixed price delivery order is scheduled for completion by August 8, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement of specialized medical devices used in insulin delivery systems, supporting federal healthcare needs. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical devices to support military healthcare programs globally, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/7/25 |